aluates Reports

$ 0.0

Automative

Global Diabetic Gastroparesis Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-23T10038

Global Diabetic Gastroparesis Market Insights Forecast to 2028

BUY CHAPTERS

Global Diabetic Gastroparesis Market Research Report 2025

Code: QYRE-Auto-23T10038

Report

June 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medtronic Inc

Sumitomo Dainippon Pharma

Abbott Laboratories

Boston Scientific Corporation

C R Bard Inc

Janssen Global Services, LLC

Evoke Pharma

Cadila Pharmaceuticals

Sanofi

Teva Pharmaceutical Industries Ltd

Pfizer Inc

Vanda Pharmaceuticals

Allergan plc

Alfasigma SpA

Diabetic Gastroparesis Market Size

The global market for Diabetic Gastroparesis was valued at US$ 2302 million in the year 2024 and is projected to reach a revised size of US$ 3310 million by 2031, growing at a CAGR of 5.4% during the forecast period.

Diabetic Gastroparesis Market

Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the vagus nerve, in cases where the blood glucose levels remain high over a longer duration. Diabetes gastroparesis is usually diagnosed with the help of imaging techniques such as ultrasound and x-ray, which is accompanied by the intake of radio isotopic meals containing barium, or using hematological / blood tests, and endoscopic techniques. There has been a marked increase in the prevalence of diabetes, especially in the developing countries, including China, India, Brazil, and some other Asian countries, leading to increasing incidence of diabetic neuropathy and consequent rise in diabetes gastroparesis around the world.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Diabetic Gastroparesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Gastroparesis.

The Diabetic Gastroparesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetic Gastroparesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetic Gastroparesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diabetic Gastroparesis Market Report

Report Metric	Details
Report Name	Diabetic Gastroparesis Market
Accounted market size in year	US$ 2302 million
Forecasted market size in 2031	US$ 3310 million
CAGR	5.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Drugs Surgical Treatment Products
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic, Sumitomo Dainippon Pharma, Abbott Laboratories, Boston Scientific Corporation, C. R. Bard, Inc, Janssen Global Services, LLC, Alfasigma SpA, Evoke Pharma, Cadila Pharmaceuticals, Sanofi, Teva Pharmaceutical Industries Ltd, Pfizer, Vanda Pharmaceuticals, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Gastroparesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diabetic Gastroparesis Market growing?

Ans: The Diabetic Gastroparesis Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the Diabetic Gastroparesis Market size in 2031?

Ans: The Diabetic Gastroparesis Market size in 2031 will be US$ 3310 million.

Who are the main players in the Diabetic Gastroparesis Market report?

Ans: The main players in the Diabetic Gastroparesis Market are Medtronic, Sumitomo Dainippon Pharma, Abbott Laboratories, Boston Scientific Corporation, C. R. Bard, Inc, Janssen Global Services, LLC, Alfasigma SpA, Evoke Pharma, Cadila Pharmaceuticals, Sanofi, Teva Pharmaceutical Industries Ltd, Pfizer, Vanda Pharmaceuticals, Allergan

What are the Application segmentation covered in the Diabetic Gastroparesis Market report?

Ans: The Applications covered in the Diabetic Gastroparesis Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Diabetic Gastroparesis Market report?

Ans: The Types covered in the Diabetic Gastroparesis Market report are Drugs, Surgical Treatment Products

Recommended Reports

Diabetes Management

Diabetic Complications

Therapeutics & Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetic Gastroparesis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Drugs

1.2.3 Surgical Treatment Products

1.3 Market by Application

1.3.1 Global Diabetic Gastroparesis Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetic Gastroparesis Market Perspective (2020-2031)

2.2 Global Diabetic Gastroparesis Growth Trends by Region

2.2.1 Global Diabetic Gastroparesis Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Diabetic Gastroparesis Historic Market Size by Region (2020-2025)

2.2.3 Diabetic Gastroparesis Forecasted Market Size by Region (2026-2031)

2.3 Diabetic Gastroparesis Market Dynamics

2.3.1 Diabetic Gastroparesis Industry Trends

2.3.2 Diabetic Gastroparesis Market Drivers

2.3.3 Diabetic Gastroparesis Market Challenges

2.3.4 Diabetic Gastroparesis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diabetic Gastroparesis Players by Revenue

3.1.1 Global Top Diabetic Gastroparesis Players by Revenue (2020-2025)

3.1.2 Global Diabetic Gastroparesis Revenue Market Share by Players (2020-2025)

3.2 Global Diabetic Gastroparesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Diabetic Gastroparesis Revenue

3.4 Global Diabetic Gastroparesis Market Concentration Ratio

3.4.1 Global Diabetic Gastroparesis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetic Gastroparesis Revenue in 2024

3.5 Global Key Players of Diabetic Gastroparesis Head office and Area Served

3.6 Global Key Players of Diabetic Gastroparesis, Product and Application

3.7 Global Key Players of Diabetic Gastroparesis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Gastroparesis Breakdown Data by Type

4.1 Global Diabetic Gastroparesis Historic Market Size by Type (2020-2025)

4.2 Global Diabetic Gastroparesis Forecasted Market Size by Type (2026-2031)

5 Diabetic Gastroparesis Breakdown Data by Application

5.1 Global Diabetic Gastroparesis Historic Market Size by Application (2020-2025)

5.2 Global Diabetic Gastroparesis Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Diabetic Gastroparesis Market Size (2020-2031)

6.2 North America Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Diabetic Gastroparesis Market Size by Country (2020-2025)

6.4 North America Diabetic Gastroparesis Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diabetic Gastroparesis Market Size (2020-2031)

7.2 Europe Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Diabetic Gastroparesis Market Size by Country (2020-2025)

7.4 Europe Diabetic Gastroparesis Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diabetic Gastroparesis Market Size (2020-2031)

8.2 Asia-Pacific Diabetic Gastroparesis Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Diabetic Gastroparesis Market Size by Region (2020-2025)

8.4 Asia-Pacific Diabetic Gastroparesis Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diabetic Gastroparesis Market Size (2020-2031)

9.2 Latin America Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Diabetic Gastroparesis Market Size by Country (2020-2025)

9.4 Latin America Diabetic Gastroparesis Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diabetic Gastroparesis Market Size (2020-2031)

10.2 Middle East & Africa Diabetic Gastroparesis Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Diabetic Gastroparesis Market Size by Country (2020-2025)

10.4 Middle East & Africa Diabetic Gastroparesis Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medtronic

11.1.1 Medtronic Company Details

11.1.2 Medtronic Business Overview

11.1.3 Medtronic Diabetic Gastroparesis Introduction

11.1.4 Medtronic Revenue in Diabetic Gastroparesis Business (2020-2025)

11.1.5 Medtronic Recent Development

11.2 Sumitomo Dainippon Pharma

11.2.1 Sumitomo Dainippon Pharma Company Details

11.2.2 Sumitomo Dainippon Pharma Business Overview

11.2.3 Sumitomo Dainippon Pharma Diabetic Gastroparesis Introduction

11.2.4 Sumitomo Dainippon Pharma Revenue in Diabetic Gastroparesis Business (2020-2025)

11.2.5 Sumitomo Dainippon Pharma Recent Development

11.3 Abbott Laboratories

11.3.1 Abbott Laboratories Company Details

11.3.2 Abbott Laboratories Business Overview

11.3.3 Abbott Laboratories Diabetic Gastroparesis Introduction

11.3.4 Abbott Laboratories Revenue in Diabetic Gastroparesis Business (2020-2025)

11.3.5 Abbott Laboratories Recent Development

11.4 Boston Scientific Corporation

11.4.1 Boston Scientific Corporation Company Details

11.4.2 Boston Scientific Corporation Business Overview

11.4.3 Boston Scientific Corporation Diabetic Gastroparesis Introduction

11.4.4 Boston Scientific Corporation Revenue in Diabetic Gastroparesis Business (2020-2025)

11.4.5 Boston Scientific Corporation Recent Development

11.5 C. R. Bard, Inc

11.5.1 C. R. Bard, Inc Company Details

11.5.2 C. R. Bard, Inc Business Overview

11.5.3 C. R. Bard, Inc Diabetic Gastroparesis Introduction

11.5.4 C. R. Bard, Inc Revenue in Diabetic Gastroparesis Business (2020-2025)

11.5.5 C. R. Bard, Inc Recent Development

11.6 Janssen Global Services, LLC

11.6.1 Janssen Global Services, LLC Company Details

11.6.2 Janssen Global Services, LLC Business Overview

11.6.3 Janssen Global Services, LLC Diabetic Gastroparesis Introduction

11.6.4 Janssen Global Services, LLC Revenue in Diabetic Gastroparesis Business (2020-2025)

11.6.5 Janssen Global Services, LLC Recent Development

11.7 Alfasigma SpA

11.7.1 Alfasigma SpA Company Details

11.7.2 Alfasigma SpA Business Overview

11.7.3 Alfasigma SpA Diabetic Gastroparesis Introduction

11.7.4 Alfasigma SpA Revenue in Diabetic Gastroparesis Business (2020-2025)

11.7.5 Alfasigma SpA Recent Development

11.8 Evoke Pharma

11.8.1 Evoke Pharma Company Details

11.8.2 Evoke Pharma Business Overview

11.8.3 Evoke Pharma Diabetic Gastroparesis Introduction

11.8.4 Evoke Pharma Revenue in Diabetic Gastroparesis Business (2020-2025)

11.8.5 Evoke Pharma Recent Development

11.9 Cadila Pharmaceuticals

11.9.1 Cadila Pharmaceuticals Company Details

11.9.2 Cadila Pharmaceuticals Business Overview

11.9.3 Cadila Pharmaceuticals Diabetic Gastroparesis Introduction

11.9.4 Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025)

11.9.5 Cadila Pharmaceuticals Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Details

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Diabetic Gastroparesis Introduction

11.10.4 Sanofi Revenue in Diabetic Gastroparesis Business (2020-2025)

11.10.5 Sanofi Recent Development

11.11 Teva Pharmaceutical Industries Ltd

11.11.1 Teva Pharmaceutical Industries Ltd Company Details

11.11.2 Teva Pharmaceutical Industries Ltd Business Overview

11.11.3 Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Introduction

11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Diabetic Gastroparesis Business (2020-2025)

11.11.5 Teva Pharmaceutical Industries Ltd Recent Development

11.12 Pfizer

11.12.1 Pfizer Company Details

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Diabetic Gastroparesis Introduction

11.12.4 Pfizer Revenue in Diabetic Gastroparesis Business (2020-2025)

11.12.5 Pfizer Recent Development

11.13 Vanda Pharmaceuticals

11.13.1 Vanda Pharmaceuticals Company Details

11.13.2 Vanda Pharmaceuticals Business Overview

11.13.3 Vanda Pharmaceuticals Diabetic Gastroparesis Introduction

11.13.4 Vanda Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025)

11.13.5 Vanda Pharmaceuticals Recent Development

11.14 Allergan

11.14.1 Allergan Company Details

11.14.2 Allergan Business Overview

11.14.3 Allergan Diabetic Gastroparesis Introduction

11.14.4 Allergan Revenue in Diabetic Gastroparesis Business (2020-2025)

11.14.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Sumitomo Dainippon Pharma

Abbott Laboratories

Boston Scientific Corporation

C R Bard Inc

Janssen Global Services, LLC

Evoke Pharma

Cadila Pharmaceuticals

Sanofi

Teva Pharmaceutical Industries Ltd

Pfizer Inc

Vanda Pharmaceuticals

Allergan plc

Alfasigma SpA

List of Tables

Table 1. Global Diabetic Gastroparesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Drugs

Table 3. Key Players of Surgical Treatment Products

Table 4. Global Diabetic Gastroparesis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Diabetic Gastroparesis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Diabetic Gastroparesis Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Diabetic Gastroparesis Market Share by Region (2020-2025)

Table 8. Global Diabetic Gastroparesis Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Diabetic Gastroparesis Market Share by Region (2026-2031)

Table 10. Diabetic Gastroparesis Market Trends

Table 11. Diabetic Gastroparesis Market Drivers

Table 12. Diabetic Gastroparesis Market Challenges

Table 13. Diabetic Gastroparesis Market Restraints

Table 14. Global Diabetic Gastroparesis Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Diabetic Gastroparesis Market Share by Players (2020-2025)

Table 16. Global Top Diabetic Gastroparesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Gastroparesis as of 2024)

Table 17. Ranking of Global Top Diabetic Gastroparesis Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Diabetic Gastroparesis Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Diabetic Gastroparesis, Headquarters and Area Served

Table 20. Global Key Players of Diabetic Gastroparesis, Product and Application

Table 21. Global Key Players of Diabetic Gastroparesis, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Diabetic Gastroparesis Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Diabetic Gastroparesis Revenue Market Share by Type (2020-2025)

Table 25. Global Diabetic Gastroparesis Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Diabetic Gastroparesis Revenue Market Share by Type (2026-2031)

Table 27. Global Diabetic Gastroparesis Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Diabetic Gastroparesis Revenue Market Share by Application (2020-2025)

Table 29. Global Diabetic Gastroparesis Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Diabetic Gastroparesis Revenue Market Share by Application (2026-2031)

Table 31. North America Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Diabetic Gastroparesis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Diabetic Gastroparesis Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Diabetic Gastroparesis Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Diabetic Gastroparesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Diabetic Gastroparesis Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Diabetic Gastroparesis Market Size by Country (2026-2031) & (US$ Million)

Table 46. Medtronic Company Details

Table 47. Medtronic Business Overview

Table 48. Medtronic Diabetic Gastroparesis Product

Table 49. Medtronic Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 50. Medtronic Recent Development

Table 51. Sumitomo Dainippon Pharma Company Details

Table 52. Sumitomo Dainippon Pharma Business Overview

Table 53. Sumitomo Dainippon Pharma Diabetic Gastroparesis Product

Table 54. Sumitomo Dainippon Pharma Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 55. Sumitomo Dainippon Pharma Recent Development

Table 56. Abbott Laboratories Company Details

Table 57. Abbott Laboratories Business Overview

Table 58. Abbott Laboratories Diabetic Gastroparesis Product

Table 59. Abbott Laboratories Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 60. Abbott Laboratories Recent Development

Table 61. Boston Scientific Corporation Company Details

Table 62. Boston Scientific Corporation Business Overview

Table 63. Boston Scientific Corporation Diabetic Gastroparesis Product

Table 64. Boston Scientific Corporation Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 65. Boston Scientific Corporation Recent Development

Table 66. C. R. Bard, Inc Company Details

Table 67. C. R. Bard, Inc Business Overview

Table 68. C. R. Bard, Inc Diabetic Gastroparesis Product

Table 69. C. R. Bard, Inc Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 70. C. R. Bard, Inc Recent Development

Table 71. Janssen Global Services, LLC Company Details

Table 72. Janssen Global Services, LLC Business Overview

Table 73. Janssen Global Services, LLC Diabetic Gastroparesis Product

Table 74. Janssen Global Services, LLC Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 75. Janssen Global Services, LLC Recent Development

Table 76. Alfasigma SpA Company Details

Table 77. Alfasigma SpA Business Overview

Table 78. Alfasigma SpA Diabetic Gastroparesis Product

Table 79. Alfasigma SpA Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 80. Alfasigma SpA Recent Development

Table 81. Evoke Pharma Company Details

Table 82. Evoke Pharma Business Overview

Table 83. Evoke Pharma Diabetic Gastroparesis Product

Table 84. Evoke Pharma Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 85. Evoke Pharma Recent Development

Table 86. Cadila Pharmaceuticals Company Details

Table 87. Cadila Pharmaceuticals Business Overview

Table 88. Cadila Pharmaceuticals Diabetic Gastroparesis Product

Table 89. Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 90. Cadila Pharmaceuticals Recent Development

Table 91. Sanofi Company Details

Table 92. Sanofi Business Overview

Table 93. Sanofi Diabetic Gastroparesis Product

Table 94. Sanofi Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 95. Sanofi Recent Development

Table 96. Teva Pharmaceutical Industries Ltd Company Details

Table 97. Teva Pharmaceutical Industries Ltd Business Overview

Table 98. Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Product

Table 99. Teva Pharmaceutical Industries Ltd Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 100. Teva Pharmaceutical Industries Ltd Recent Development

Table 101. Pfizer Company Details

Table 102. Pfizer Business Overview

Table 103. Pfizer Diabetic Gastroparesis Product

Table 104. Pfizer Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 105. Pfizer Recent Development

Table 106. Vanda Pharmaceuticals Company Details

Table 107. Vanda Pharmaceuticals Business Overview

Table 108. Vanda Pharmaceuticals Diabetic Gastroparesis Product

Table 109. Vanda Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 110. Vanda Pharmaceuticals Recent Development

Table 111. Allergan Company Details

Table 112. Allergan Business Overview

Table 113. Allergan Diabetic Gastroparesis Product

Table 114. Allergan Revenue in Diabetic Gastroparesis Business (2020-2025) & (US$ Million)

Table 115. Allergan Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Diabetic Gastroparesis Picture

Figure 2. Global Diabetic Gastroparesis Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Diabetic Gastroparesis Market Share by Type: 2024 VS 2031

Figure 4. Drugs Features

Figure 5. Surgical Treatment Products Features

Figure 6. Global Diabetic Gastroparesis Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Diabetic Gastroparesis Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Diabetic Gastroparesis Report Years Considered

Figure 12. Global Diabetic Gastroparesis Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Diabetic Gastroparesis Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Diabetic Gastroparesis Market Share by Region: 2024 VS 2031

Figure 15. Global Diabetic Gastroparesis Market Share by Players in 2024

Figure 16. Global Top Diabetic Gastroparesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Gastroparesis as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Diabetic Gastroparesis Revenue in 2024

Figure 18. North America Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Diabetic Gastroparesis Market Share by Country (2020-2031)

Figure 20. United States Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Diabetic Gastroparesis Market Share by Country (2020-2031)

Figure 24. Germany Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Diabetic Gastroparesis Market Share by Region (2020-2031)

Figure 32. China Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Diabetic Gastroparesis Market Share by Country (2020-2031)

Figure 40. Mexico Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Diabetic Gastroparesis Market Share by Country (2020-2031)

Figure 44. Turkey Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Diabetic Gastroparesis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Medtronic Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 48. Sumitomo Dainippon Pharma Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 49. Abbott Laboratories Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 50. Boston Scientific Corporation Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 51. C. R. Bard, Inc Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 52. Janssen Global Services, LLC Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 53. Alfasigma SpA Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 54. Evoke Pharma Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 55. Cadila Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 56. Sanofi Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 57. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 58. Pfizer Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 59. Vanda Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 60. Allergan Revenue Growth Rate in Diabetic Gastroparesis Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Diabetic Gastroparesis Treatment Products Market Insights Forecast to 2030

Global Diabetic Gastroparesis Drugs Market Insights Forecast to 2030

Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastroparesis Treatment Market Research Report 2024

Global Idiopathic Gastroparesis Drugs Market Insights Forecast to 2030

Gastroparesis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Treatment for Gastroparesis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Anti diabetes Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Mellitus Treatment Market Insights Forecast to 2030

Global Gastroparesis Treatment Products Market Insights Forecast to 2030

Global Needle Free Diabetes Care Market Research Report 2024

Diabetes Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Management Equipment Market Research Report 2024

Global Disposable Diabetes Devices Market Research Report 2024

Global Diabetes Associated Ophthalmic Treatment Market Research Report 2025

Gastric Stimulation System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insulin Pumps and Accessories Market Research Report 2024

Global Type 2 Diabetes Medicines Market Research Report 2024

Global Gastrointestinal Drugs Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions